# Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia

> **NCT06497062** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 47 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** sonrotoclax
- **DRUG:** idarubicin/daunorubicin
- **DRUG:** Cytarabine
- **DRUG:** Azacitidine
- **PROCEDURE:** allo-HSCT

## Key facts

- **NCT ID:** NCT06497062
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-30
- **Primary completion:** 2027-10-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 47 (ESTIMATED)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06497062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06497062, "Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06497062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*